MétaCan
Menu
Back to cohort
Record W4413844625 · doi:10.1158/0008-5472.can-25-0006

MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis

2025· article· en· W4413844625 on OpenAlexaff
Yi-Ta Tsai, En-Ting Liu, Ming‐Hsin Yang, Chien‐Chang Kao, Sheue‐Fen Tzeng, Yu-Chi Chen, Pei‐Wen Hsiao, An‐Chieh Feng, Grace S. Shieh, Mong‐Hsun Tsai, Shau‐Kwaun Chen, Yi‐Lin Chiu, Chin Li Chen, Sheng‐Tang Wu, En Meng, Wen‐Chiuan Tsai, Tai‐Kuang Chao, Guang-Huan Sun, Sun‐Yran Chang, Mien‐Chie Hung, Tai‐Lung Cha

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicImmune cells in cancer
Canadian institutionsNational Defence Medical Centre
FundersAcademia SinicaTaipei Veterans General HospitalNational Defense Medical CenterNational Science and Technology Council
KeywordsMetastasisRHOACancer cellBiologyAnoikisCell biologyCell migrationCancer researchCancerCellSignal transductionGenetics

Abstract

fetched live from OpenAlex

Metastasis, the leading cause of cancer-related mortality, remains the most critical challenge in cancer treatment. Cancer cells can adopt amoeboid migration to facilitate metastasis, highlighting the need to elucidate the molecular pathways regulating the amoeboid migration phenotype. In this study, we identified that MYADM, a transmembrane protein expressed during myeloid cell maturation, enabled cancer cells to acquire amoeboid migration plasticity, promoting metastasis and contributing to poor patient outcomes. Cancer cells exploited MYADM-mediated adhesion and migration to mimic leukocyte trafficking. By interacting with RhoGDI, MYADM activated RhoA-mediated leukocyte trafficking-associated gene enrichment, invasiveness, membrane blebbing, and anoikis resistance. MYADM modulated chromatin accessibility-regulatory genes, influencing intermediate filament cytoskeleton dynamics of cancer cells and tumor tissues. MYADM loss in cancer cells triggered chromatin accessibility-driven death signaling, blocking metastasis, which was not observed in monocytes. These findings position MYADM as a potential therapeutic target to disrupt metastasis, offering avenues for clinical intervention. SIGNIFICANCE: Targeting MYADM, which interacts with RhoGDI to induce RhoA-driven amoeboid migration plasticity and chromatin dynamics, is a strategy to block metastatic progression that selectively impairs cancer cell survival.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.402
Teacher spread0.356 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicImmune cells in cancerFrench-language works237,207